U.S. Department of Veterans Affairs Connecticut Healthcare System, 950 Campbell Avenue, West Haven, CT, USA.
Department of Internal Medicine, Yale School of Medicine, 300 George Street, Suite 901, New Haven, CT, 06511, USA.
Psychiatr Q. 2022 Sep;93(3):737-752. doi: 10.1007/s11126-022-09989-0. Epub 2022 Jun 4.
In spite of evidence of increasing prevalence of substance use disorders (SUDs) among women, there is little information on gender differences in SUD treatment use. Nationally representative survey data were used to compare specialized SUD treatment among women and men with past-year DSM-5 SUD diagnoses (N = 5,789, 42.8% women). An estimated 10.7% of women and 9.9% of men (p = 0.45) received SUD treatment. Those who received treatment among both men and women had more problems than others. Five variables were independently associated with receipt of past-year treatment in both women and men and while five others were independently associated with receipt of treatment for only one gender. Interaction analysis, however, revealed no statistically significant gender differences in any correlate of treatment receipt. Although men were more likely to have SUDs than women, there were no significant differences by gender in rates or correlates of service use.
尽管有证据表明女性物质使用障碍(SUD)的患病率在不断增加,但关于 SUD 治疗使用方面的性别差异的信息却很少。本研究使用全国代表性调查数据比较了有过去一年 DSM-5 SUD 诊断的女性和男性(N=5789,女性占 42.8%)在专门的 SUD 治疗方面的差异。估计有 10.7%的女性和 9.9%的男性(p=0.45)接受了 SUD 治疗。在男性和女性中,接受治疗的人比其他人的问题更多。有五个变量在男性和女性中均与过去一年的治疗有关,而另外五个变量仅与一种性别的治疗有关。然而,交互分析显示,在治疗接受情况的任何相关因素方面,性别差异均无统计学意义。尽管男性的 SUD 比女性更常见,但在服务使用的比率或相关性方面,性别差异并不显著。